Cholestatic hepatitis with ciprofloxacin therapy: A Case Report

<p>Ciprofloxacin has generally been well-tolerated and is the commonly prescribed fluoroquinolone antibiotic for treatment of urinary tract and gastrointestinal infection. The adverse effects on the liver usually range from asymptomatic elevation of liver enzymes to fulminant hepatitis. Howeve...

Full description

Bibliographic Details
Main Authors: A. R. M. Misthaq, S. Pirasath, N. D. Jayaweerabandara, A. G. H. Sugathapala
Format: Article
Language:English
Published: Sri Lankan Society for Microbiology 2019-10-01
Series:Sri Lankan Journal of Infectious Diseases
Subjects:
Online Access:https://sljid.sljol.info/articles/8256
_version_ 1818468438648029184
author A. R. M. Misthaq
S. Pirasath
N. D. Jayaweerabandara
A. G. H. Sugathapala
author_facet A. R. M. Misthaq
S. Pirasath
N. D. Jayaweerabandara
A. G. H. Sugathapala
author_sort A. R. M. Misthaq
collection DOAJ
description <p>Ciprofloxacin has generally been well-tolerated and is the commonly prescribed fluoroquinolone antibiotic for treatment of urinary tract and gastrointestinal infection. The adverse effects on the liver usually range from asymptomatic elevation of liver enzymes to fulminant hepatitis. However, acute fulminant hepatitis and cholestatic hepatitis are reported rarely in literature<strong>. </strong>Here,<strong> </strong>we report a case of ciprofloxacin induced cholestatic hepatitis in a 52 year old woman<strong> </strong>following intravenous ciprofloxacin for acute gastroenteritis.</p>
first_indexed 2024-04-13T21:12:12Z
format Article
id doaj.art-6e5d1b94ddd643d7901e1be1c50a57d1
institution Directory Open Access Journal
issn 2012-8169
2448-9654
language English
last_indexed 2024-04-13T21:12:12Z
publishDate 2019-10-01
publisher Sri Lankan Society for Microbiology
record_format Article
series Sri Lankan Journal of Infectious Diseases
spelling doaj.art-6e5d1b94ddd643d7901e1be1c50a57d12022-12-22T02:29:48ZengSri Lankan Society for MicrobiologySri Lankan Journal of Infectious Diseases2012-81692448-96542019-10-019215615910.4038/sljid.v9i2.82565824Cholestatic hepatitis with ciprofloxacin therapy: A Case ReportA. R. M. Misthaq0S. Pirasath1N. D. Jayaweerabandara2A. G. H. Sugathapala3Colombo South Teaching Hospital, KalubowilaColombo South Teaching Hospital, KalubowilaColombo South Teaching Hospital, KalubowilaColombo South Teaching Hospital, Kalubowila<p>Ciprofloxacin has generally been well-tolerated and is the commonly prescribed fluoroquinolone antibiotic for treatment of urinary tract and gastrointestinal infection. The adverse effects on the liver usually range from asymptomatic elevation of liver enzymes to fulminant hepatitis. However, acute fulminant hepatitis and cholestatic hepatitis are reported rarely in literature<strong>. </strong>Here,<strong> </strong>we report a case of ciprofloxacin induced cholestatic hepatitis in a 52 year old woman<strong> </strong>following intravenous ciprofloxacin for acute gastroenteritis.</p>https://sljid.sljol.info/articles/8256ciprofloxacin, cholestasis, hepatitis, toxicity
spellingShingle A. R. M. Misthaq
S. Pirasath
N. D. Jayaweerabandara
A. G. H. Sugathapala
Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
Sri Lankan Journal of Infectious Diseases
ciprofloxacin, cholestasis, hepatitis, toxicity
title Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
title_full Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
title_fullStr Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
title_full_unstemmed Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
title_short Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
title_sort cholestatic hepatitis with ciprofloxacin therapy a case report
topic ciprofloxacin, cholestasis, hepatitis, toxicity
url https://sljid.sljol.info/articles/8256
work_keys_str_mv AT armmisthaq cholestatichepatitiswithciprofloxacintherapyacasereport
AT spirasath cholestatichepatitiswithciprofloxacintherapyacasereport
AT ndjayaweerabandara cholestatichepatitiswithciprofloxacintherapyacasereport
AT aghsugathapala cholestatichepatitiswithciprofloxacintherapyacasereport